{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T04:19:31Z","timestamp":1788668371262,"version":"build-2803163510"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T00:00:00Z","timestamp":1764201600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T00:00:00Z","timestamp":1764201600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["860462"],"award-info":[{"award-number":["860462"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-26524-w","type":"journal-article","created":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T13:10:52Z","timestamp":1764249052000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Pulsed electromagnetic field stimulation subtly modulates doxorubicin sensitivity in a spheroid co-culture model of osteosarcoma"],"prefix":"10.1038","volume":"15","author":[{"given":"Ksenia","family":"Menshikh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myriam","family":"Antonaci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Radini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Salati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farah","family":"Daou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Cochis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lia","family":"Rimondini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,27]]},"reference":[{"key":"26524_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1002\/ijc.24320","volume":"125","author":"L Mirabello","year":"2009","unstructured":"Mirabello, L., Troisi, R. J. & Savage, S. A. International osteosarcoma incidence patterns in children and adolescents, middle ages and elderly persons. Int. J. Cancer 125, 229\u2013234 (2009).","journal-title":"Int. J. Cancer"},{"key":"26524_CR2","doi-asserted-by":"publisher","first-page":"117212","DOI":"10.1016\/j.bone.2024.117212","volume":"188","author":"J Lai","year":"2024","unstructured":"Lai, J., Li, X., Liu, W., Liufu, Q. & Zhong, C. Global, regional, and National burden and trends analysis of malignant neoplasm of bone and articular cartilage from 1990 to 2021: A systematic analysis for the global burden of disease study 2021. Bone 188, 117212 (2024).","journal-title":"Bone"},{"key":"26524_CR3","doi-asserted-by":"crossref","unstructured":"Misaghi, A., Goldin, A., Awad, M. & Kulidjian, A. A. Osteosarcoma: A comprehensive review. SICOT J. 4, (2018).","DOI":"10.1051\/sicotj\/2017028"},{"key":"26524_CR4","doi-asserted-by":"crossref","unstructured":"Shoaib, Z., Fan, T. M. & Irudayaraj, J. M. K. Osteosarcoma mechanobiology and therapeutic targets. Br. J. Pharmacol. 179, 201\u2013217 (2022).","DOI":"10.1111\/bph.15713"},{"key":"26524_CR5","doi-asserted-by":"crossref","unstructured":"Freeman, F. E., Burdis, R., Mahon, O. R., Kelly, D. J. & Artzi, N. A. Spheroid model of early and late-stage osteosarcoma mimicking the divergent relationship between tumor elimination and bone regeneration. Adv. Healthc. Mater. 11, (2022).","DOI":"10.1002\/adhm.202101296"},{"key":"26524_CR6","doi-asserted-by":"crossref","unstructured":"Cornelio, N. & Burudpakdee, C. A. Guideline-Based Estimate of health care resource use and cost of metastatic unresectable osteosarcoma. Value Health 17, A629\u2013A630 (2014).","DOI":"10.1016\/j.jval.2014.08.2249"},{"key":"26524_CR7","doi-asserted-by":"publisher","unstructured":"Jafari, F. et al. Osteosarcoma: A comprehensive review of management and treatment strategies. Ann. Diagn. Pathol. 49, 151654. https:\/\/doi.org\/10.1016\/j.anndiagpath.2020.151654 (2020).","DOI":"10.1016\/j.anndiagpath.2020.151654"},{"key":"26524_CR8","doi-asserted-by":"publisher","unstructured":"Zhao, X., Wu, Q., Gong, X., Liu, J. & Ma, Y. Osteosarcoma: A review of current and future therapeutic approaches. BioMed. Eng. Online 20. https:\/\/doi.org\/10.1186\/s12938-021-00860-0 (2021).","DOI":"10.1186\/s12938-021-00860-0"},{"key":"26524_CR9","doi-asserted-by":"publisher","unstructured":"Brookes, M. J. et al. Surgical advances in osteosarcoma. Cancers 13, 1\u201326. https:\/\/doi.org\/10.3390\/cancers13030388 (2021).","DOI":"10.3390\/cancers13030388"},{"key":"26524_CR10","doi-asserted-by":"publisher","first-page":"a029652","DOI":"10.1101\/cshperspect.a029652","volume":"7","author":"A Fortunato","year":"2017","unstructured":"Fortunato, A. et al. Natural selection in cancer biology: From molecular snowflakes to trait hallmarks. Cold Spring Harb Perspect. Med. 7, a029652 (2017).","journal-title":"Cold Spring Harb Perspect. Med."},{"key":"26524_CR11","doi-asserted-by":"publisher","first-page":"3128","DOI":"10.1002\/cam4.861","volume":"5","author":"M Vadal\u00e0","year":"2016","unstructured":"Vadal\u00e0, M. et al. Mechanisms and therapeutic effectiveness of pulsed electromagnetic field therapy in oncology. Cancer Med. 5, 3128\u20133139 (2016).","journal-title":"Cancer Med."},{"key":"26524_CR12","doi-asserted-by":"crossref","unstructured":"Mansourian, M. & Shanei, A. Evaluation of pulsed electromagnetic field effects: A systematic review and meta-analysis on highlights of two decades of research in vitro studies. Biomed Res. Int. 2021 (2021).","DOI":"10.1155\/2021\/6647497"},{"key":"26524_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/15368378.2019.1567527","volume":"38","author":"E Azadian","year":"2019","unstructured":"Azadian, E., Arjmand, B., Khodaii, Z. & Ardeshirylajimi, A. A comprehensive overview on utilizing electromagnetic fields in bone regenerative medicine. Electromagn. Biol. Med. 38, 1\u201320 (2019).","journal-title":"Electromagn. Biol. Med."},{"key":"26524_CR14","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3390\/reports5010003","volume":"5","author":"R Roberti","year":"2022","unstructured":"Roberti, R. et al. High-intensity, low-frequency pulsed electromagnetic field as an odd treatment in a patient with mixed foot ulcer: A case report. Reports 5, 3 (2022).","journal-title":"Reports"},{"key":"26524_CR15","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.asj.2009.02.001","volume":"29","author":"B Strauch","year":"2009","unstructured":"Strauch, B., Herman, C., Dabb, R., Ignarro, L. J. & Pilla, A. A. Evidence-based use of pulsed electromagnetic field therapy in clinical plastic surgery. Aesthet. Surg. J. 29, 135\u2013143 (2009).","journal-title":"Aesthet. Surg. J."},{"key":"26524_CR16","doi-asserted-by":"publisher","unstructured":"Iannitti, T., Palmieri, B., Fistetto, E. & Rottigni. Pulsed electromagnetic field therapy for management of osteoarthritis-related pain, stiffness and physical function: Clinical experience in the elderly. Clin. Interv. Aging 1289 https:\/\/doi.org\/10.2147\/CIA.S35926 (2013).","DOI":"10.2147\/CIA.S35926"},{"key":"26524_CR17","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1002\/bem.20703","volume":"33","author":"K Hug","year":"2012","unstructured":"Hug, K. & R\u00f6\u00f6sli, M. Therapeutic effects of whole-body devices applying pulsed electromagnetic fields (PEMF): A systematic literature review. Bioelectromagnetics 33, 95\u2013105 (2012).","journal-title":"Bioelectromagnetics"},{"key":"26524_CR18","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1002\/bem.10054","volume":"23","author":"MJ Ruiz-G\u00f3mez","year":"2002","unstructured":"Ruiz-G\u00f3mez, M. J. et al. Influence of 1 and 25 Hz, 1.5 mT magnetic fields on antitumor drug potency in a human adenocarcinoma cell line. Bioelectromagnetics 23, 578\u2013525 (2002).","journal-title":"Bioelectromagnetics"},{"key":"26524_CR19","doi-asserted-by":"publisher","first-page":"61","DOI":"10.21873\/invivo.11026","volume":"31","author":"Y MURAMATSU","year":"2017","unstructured":"MURAMATSU, Y., MATSUI, T., DEIE, M. & SATO, K. Pulsed electromagnetic field stimulation promotes anti-cell proliferative activity in Doxorubicin-treated mouse osteosarcoma cells. Vivo (Brooklyn) 31, 61\u201368 (2017).","journal-title":"Vivo (Brooklyn)"},{"key":"26524_CR20","doi-asserted-by":"crossref","unstructured":"Tai, Y. K. et al. Modulated TRPC1 expression predicts sensitivity of breast cancer to doxorubicin and magnetic field therapy: Segue towards a precision medicine approach. Front. Oncol. 11 (2022).","DOI":"10.3389\/fonc.2021.783803"},{"key":"26524_CR21","doi-asserted-by":"publisher","first-page":"e72944","DOI":"10.1371\/journal.pone.0072944","volume":"8","author":"S Crocetti","year":"2013","unstructured":"Crocetti, S. et al. Low intensity and frequency pulsed electromagnetic fields selectively impair breast cancer cell viability. PLoS One 8, e72944 (2013).","journal-title":"PLoS One"},{"key":"26524_CR22","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s12935-014-0084-x","volume":"14","author":"N Filipovic","year":"2014","unstructured":"Filipovic, N. et al. Electromagnetic field investigation on different cancer cell lines. Cancer Cell. Int. 14, 84 (2014).","journal-title":"Cancer Cell. Int."},{"key":"26524_CR23","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.trecan.2020.10.009","volume":"7","author":"J Rodrigues","year":"2021","unstructured":"Rodrigues, J., Heinrich, M. A., Teixeira, L. M. & Prakash, J. 3D in vitro model (R)evolution: Unveiling Tumor\u2013Stroma interactions. Trends Cancer 7, 249\u2013264 (2021).","journal-title":"Trends Cancer"},{"key":"26524_CR24","doi-asserted-by":"crossref","unstructured":"Zushin, P. J. H., Mukherjee, S. & Wu, J. C. FDA modernization act 2.0: Transitioning beyond animal models with human cells, organoids, and AI\/ML-based approaches. J. Clin. Invest. 133 (2023).","DOI":"10.1172\/JCI175824"},{"key":"26524_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.trecan.2025.03.005","author":"SY Kim","year":"2025","unstructured":"Kim, S. Y., van de Wetering, M., Clevers, H. & Sanders, K. The future of tumor organoids in precision therapy. Trends Cancer https:\/\/doi.org\/10.1016\/j.trecan.2025.03.005 (2025).","journal-title":"Trends Cancer"},{"key":"26524_CR26","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.3390\/pharmaceutics12121186","volume":"12","author":"B Pinto","year":"2020","unstructured":"Pinto, B., Henriques, A. C., Silva, P. M. A. & Bousbaa, H. Three-dimensional spheroids as in vitro preclinical models for cancer research. Pharmaceutics 12, 1186 (2020).","journal-title":"Pharmaceutics"},{"key":"26524_CR27","doi-asserted-by":"crossref","unstructured":"Domingues, M. F., Silva, J. C. & Sanjuan-Alberte, P. From spheroids to bioprinting: A literature review on biomanufacturing strategies of 3D in vitro osteosarcoma models. Adv Ther. (Weinh) 7, (2024).","DOI":"10.1002\/adtp.202400047"},{"key":"26524_CR28","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1111\/jphp.12869","volume":"70","author":"M Baxter-Holland","year":"2018","unstructured":"Baxter-Holland, M. & Dass, C. R. Doxorubicin, mesenchymal stem cell toxicity and antitumour activity: Implications for clinical use. J. Pharm. Pharmacol. 70, 320\u2013327 (2018).","journal-title":"J. Pharm. Pharmacol."},{"key":"26524_CR29","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.canlet.2019.07.010","volume":"461","author":"R Burgos-Panadero","year":"2019","unstructured":"Burgos-Panadero, R. et al. The tumour microenvironment as an integrated framework to understand cancer biology. Cancer Lett. 461, 112\u2013122 (2019).","journal-title":"Cancer Lett."},{"key":"26524_CR30","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.3390\/cancers15041221","volume":"15","author":"M Cortini","year":"2023","unstructured":"Cortini, M. et al. Endogenous extracellular matrix regulates the response of osteosarcoma 3D spheroids to doxorubicin. Cancers (Basel) 15, 1221 (2023).","journal-title":"Cancers (Basel)"},{"key":"26524_CR31","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1016\/j.stemcr.2015.05.005","volume":"4","author":"S James","year":"2015","unstructured":"James, S. et al. Multiparameter analysis of human bone marrow stromal cells identifies distinct immunomodulatory and differentiation-competent subtypes. Stem Cell. Rep. 4, 1004\u20131015 (2015).","journal-title":"Stem Cell. Rep."},{"key":"26524_CR32","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1308\/rcsfdj.2024.33","volume":"15","author":"L Whitehouse","year":"2024","unstructured":"Whitehouse, L., Do, T. & Thomson, N. Optimising dental pulp stem cell adhesion on agarose scaffolds for in vitro dentinogenesis. Fac. Dent. J. 15, 112\u2013117 (2024).","journal-title":"Fac. Dent. J."},{"key":"26524_CR33","doi-asserted-by":"publisher","first-page":"5257","DOI":"10.62347\/PPEI1766","volume":"17","author":"Q Zhang","year":"2025","unstructured":"Zhang, Q. Spheroid culture of human periodontal ligament stem cells on agarose enhances stemness and osteogenic differentiation potential. Am. J. Transl. Res. 17, 5257\u20135270 (2025).","journal-title":"Am. J. Transl. Res."},{"key":"26524_CR34","unstructured":"B\u00e4cker, V. Analyze spheroid cell invasion in 3D matrix, RRID:SCR_021204. https:\/\/github.com\/MontpellierRessourcesImagerie\/imagej_macros_and_scripts\/wiki\/Analyze-Spheroid-Cell-Invasion-In-3D-Matrix (2012)."},{"key":"26524_CR35","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s12551-021-00821-w","volume":"13","author":"YM Efremov","year":"2021","unstructured":"Efremov, Y. M. et al. Mechanical properties of cell sheets and spheroids: The link between single cells and complex tissues. Biophys. Rev. 13, 541\u2013561 (2021).","journal-title":"Biophys. Rev."},{"key":"26524_CR36","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s40580-017-0099-9","volume":"4","author":"SO Kim","year":"2017","unstructured":"Kim, S. O., Kim, J., Okajima, T. & Cho, N. J. Mechanical properties of paraformaldehyde-treated individual cells investigated by atomic force microscopy and scanning ion conductance microscopy. Nano Converg. 4, 5 (2017).","journal-title":"Nano Converg"},{"key":"26524_CR37","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1002\/cm.21217","volume":"72","author":"M Targosz-Korecka","year":"2015","unstructured":"Targosz-Korecka, M., Daniel Brzezinka, G., Danilkiewicz, J., Rajfur, Z. & Szymonski, M. Glutaraldehyde fixation preserves the trend of elasticity alterations for endothelial cells exposed to <\u2009scp\u2009>\u2009TNF \u2010\u03b1. Cytoskeleton 72, 124\u2013130 (2015).","journal-title":"Cytoskeleton"},{"key":"26524_CR38","doi-asserted-by":"crossref","unstructured":"Baek, N., Seo, O. W., Kim, M., Hulme, J. & An, S. S. A. Monitoring the effects of doxorubicin on 3D-spheroid tumor cells in real-time. Onco Targets Ther. 9, 7207\u20137218 (2016).","DOI":"10.2147\/OTT.S112566"},{"key":"26524_CR39","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1038\/s41598-023-28635-8","volume":"13","author":"P Butler","year":"2023","unstructured":"Butler, P. et al. RNA disruption is a widespread phenomenon associated with stress-induced cell death in tumour cells. Sci. Rep. 13, 1711 (2023).","journal-title":"Sci. Rep."},{"key":"26524_CR40","doi-asserted-by":"publisher","first-page":"126391","DOI":"10.1016\/j.ijbiomac.2023.126391","volume":"252","author":"Y Lin","year":"2023","unstructured":"Lin, Y. et al. Osteosarocma progression in biomimetic matrix with different stiffness: Insights from a three-dimensional printed gelatin methacrylamide hydrogel. Int. J. Biol. Macromol. 252, 126391 (2023).","journal-title":"Int. J. Biol. Macromol."},{"key":"26524_CR41","doi-asserted-by":"publisher","unstructured":"Rodrigues, J., Sarmento, B. & Pereira, C. L. Osteosarcoma tumor microenvironment: The key for the successful development of biologically relevant 3D in vitro models. In Vitro Models. https:\/\/doi.org\/10.1007\/s44164-022-00008-x (2022).","DOI":"10.1007\/s44164-022-00008-x"},{"key":"26524_CR42","first-page":"177","volume":"240","author":"RM Sutherland","year":"1988","unstructured":"Sutherland, R. M. Cell and environment interactions in tumor microregions: The multicell spheroid model. Sci. (1979). 240, 177\u2013184 (1988).","journal-title":"Sci. (1979)"},{"key":"26524_CR43","doi-asserted-by":"crossref","unstructured":"Baek, N., Seo, O. W., Lee, J., Hulme, J. & An, S. S. A. Real-time monitoring of cisplatin cytotoxicity on three-dimensional spheroid tumor cells. Drug Des. Devel Ther. 10, 2155\u20132165 (2016).","DOI":"10.2147\/DDDT.S108004"},{"key":"26524_CR44","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/s41420-024-01854-2","volume":"10","author":"E Panczyszyn","year":"2024","unstructured":"Panczyszyn, E. et al. FSP1 is a predictive biomarker of osteosarcoma cells\u2019 susceptibility to ferroptotic cell death and a potential therapeutic target. Cell. Death Discov. 10, 87 (2024).","journal-title":"Cell. Death Discov"},{"key":"26524_CR45","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.jbiotec.2014.09.005","volume":"189","author":"M Rimann","year":"2014","unstructured":"Rimann, M. et al. An in vitro osteosarcoma 3D microtissue model for drug development. J. Biotechnol. 189, 129\u2013135 (2014).","journal-title":"J. Biotechnol."},{"key":"26524_CR46","doi-asserted-by":"publisher","first-page":"100372","DOI":"10.1016\/j.jbo.2021.100372","volume":"29","author":"X Chang","year":"2021","unstructured":"Chang, X., Ma, Z., Zhu, G., Lu, Y. & Yang, J. New perspective into mesenchymal stem cells: Molecular mechanisms regulating osteosarcoma. J. Bone Oncol. 29, 100372 (2021).","journal-title":"J. Bone Oncol."},{"key":"26524_CR47","doi-asserted-by":"crossref","unstructured":"Xu, W. et al. Pulsed electromagnetic therapy in cancer treatment: Progress and outlook. VIEW 3 (2022).","DOI":"10.1002\/VIW.20220029"},{"key":"26524_CR48","doi-asserted-by":"crossref","unstructured":"Qian, S. et al. The role of BCL-2 family proteins in regulating apoptosis and cancer therapy. Front. Oncol. 12, (2022).","DOI":"10.3389\/fonc.2022.985363"},{"key":"26524_CR49","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1002\/bem.20023","volume":"25","author":"M Radeva","year":"2004","unstructured":"Radeva, M. & Berg, H. Differences in lethality between cancer cells and human lymphocytes caused by LF-electromagnetic fields. Bioelectromagnetics 25, 503\u2013507 (2004).","journal-title":"Bioelectromagnetics"},{"key":"26524_CR50","doi-asserted-by":"crossref","unstructured":"Gautreau, A., Poullet, P., Louvard, D. & Arpin, M. Ezrin, A plasma membrane\u2013microfilament linker, signals cell survival through the phosphatidylinositol 3-kinase\/Akt pathway. Proc. Natl. Acad. Sci. 96, 7300\u20137305 (1999).","DOI":"10.1073\/pnas.96.13.7300"},{"key":"26524_CR51","first-page":"101972","volume":"42","author":"S Akter","year":"2025","unstructured":"Akter, S. et al. Comprehensive in Silico characterization of nonsynonymous SNPs in the human Ezrin (EZR) gene and their role in disease pathogenesis. Biochem. Biophys. Rep. 42, 101972 (2025).","journal-title":"Biochem. Biophys. Rep."},{"key":"26524_CR52","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/nm982","volume":"10","author":"C Khanna","year":"2004","unstructured":"Khanna, C. et al. The membrane-cytoskeleton linker Ezrin is necessary for osteosarcoma metastasis. Nat. Med. 10, 182\u2013186 (2004).","journal-title":"Nat. Med."},{"key":"26524_CR53","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/s10669-007-9128-2","volume":"27","author":"MS Markov","year":"2007","unstructured":"Markov, M. S. Pulsed electromagnetic field therapy history, state of the art and future. Environmentalist 27, 465\u2013475 (2007).","journal-title":"Environmentalist"},{"key":"26524_CR54","doi-asserted-by":"publisher","first-page":"388","DOI":"10.3390\/cells9020388","volume":"9","author":"OM Elzamzamy","year":"2020","unstructured":"Elzamzamy, O. M., Penner, R. & Hazlehurst, L. A. The role of TRPC1 in modulating cancer progression. Cells 9, 388 (2020).","journal-title":"Cells"},{"key":"26524_CR55","doi-asserted-by":"publisher","first-page":"2351","DOI":"10.3390\/cancers12092351","volume":"12","author":"JIE Bruce","year":"2020","unstructured":"Bruce, J. I. E. & James, A. D. Targeting the calcium signalling machinery in cancer. Cancers (Basel) 12, 2351 (2020).","journal-title":"Cancers (Basel)"},{"key":"26524_CR56","doi-asserted-by":"crossref","unstructured":"Wang, Q., Bode, A. M. & Zhang, T. Targeting CDK1 in cancer: Mechanisms and implications. NPJ Precis. Oncol. 7, 58 (2023).","DOI":"10.1038\/s41698-023-00407-7"},{"key":"26524_CR57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41392-022-01259-6","volume":"8","author":"X Pang","year":"2023","unstructured":"Pang, X. et al. Targeting integrin pathways: Mechanisms and advances in therapy. Signal. Transduct. Target. Ther. 8, 1 (2023).","journal-title":"Signal. Transduct. Target. Ther."},{"key":"26524_CR58","doi-asserted-by":"publisher","first-page":"3075","DOI":"10.3892\/ol.2016.5060","volume":"12","author":"J Yang","year":"2016","unstructured":"Yang, J. & Wang, N. Analysis of the molecular mechanism of osteosarcoma using a bioinformatics approach. Oncol. Lett. 12, 3075\u20133080 (2016).","journal-title":"Oncol. Lett."},{"key":"26524_CR59","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/s41392-024-01828-x","volume":"9","author":"Q Shi","year":"2024","unstructured":"Shi, Q. et al. Notch signaling pathway in cancer: From mechanistic insights to targeted therapies. Signal. Transduct. Target. Ther. 9, 128 (2024).","journal-title":"Signal. Transduct. Target. Ther."},{"key":"26524_CR60","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/nrc745","volume":"2","author":"M Egeblad","year":"2002","unstructured":"Egeblad, M. & Werb, Z. New functions for the matrix metalloproteinases in cancer progression. Nat. Rev. Cancer 2, 161\u2013174 (2002).","journal-title":"Nat. Rev. Cancer"},{"key":"26524_CR61","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/S0304-3835(98)00368-1","volume":"137","author":"A Kido","year":"1999","unstructured":"Kido, A. et al. Overexpression of matrix metalloproteinase (MMP)-9 correlates with metastatic potency of spontaneous and 4-hydroxyaminoquinoline 1-oxide (4-HAQO)-induced transplantable osteosarcomas in rats. Cancer Lett. 137, 209\u2013216 (1999).","journal-title":"Cancer Lett."},{"key":"26524_CR62","doi-asserted-by":"crossref","unstructured":"Ji, Z., Shen, J., Lan, Y., Yi, Q. & Liu, H. Targeting signaling pathways in osteosarcoma: Mechanisms and clinical studies. MedComm (Beijing) 4, (2023).","DOI":"10.1002\/mco2.308"},{"key":"26524_CR63","doi-asserted-by":"publisher","first-page":"110595","DOI":"10.1016\/j.ygeno.2023.110595","volume":"115","author":"X Cai","year":"2023","unstructured":"Cai, X. & Zhu, S. Prognosis-related VDAC1 regulates the proliferation and apoptosis of osteosarcoma cells via the MAPK signaling pathway. Genomics 115, 110595 (2023).","journal-title":"Genomics"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-26524-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-26524-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-26524-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T14:04:01Z","timestamp":1764252241000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-26524-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,27]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["26524"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-26524-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,27]]},"assertion":[{"value":"12 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"42441"}}